High-frequency oscillations (HFO) are a promising biomarker for the identification of
epileptogenic tissue. While HFO rates have been shown to predict seizure outcome, it is not …

Objective This study investigates high‐frequency oscillations (HFO s; 65–600 Hz) as a
biomarker of epileptogenic brain and explores three barriers to their clinical translation:(1) …

Over 20 years of enthusiastic research have served to establish high frequency oscillations
(HFO) as a promising biomarker of epileptogenicity, both in animal models and in refractory …

Objectives High‐frequency oscillations (HFO s) represent a novel electrophysiologic marker
of endogenous epileptogenicity. Clinically, this propensity can be utilized to more accurately …

Objective High frequency oscillations (HFO s) have recently been recorded in epilepsy
patients and proposed as possible novel biomarkers of epileptogenicity. Investigation of …

Background High-frequency oscillation (HFO) represents a promising biomarker of
epileptogenicity. However, the significant interindividual differences among patients limit its …

Pathological high frequency oscillations (HFOs) are putative neurophysiological biomarkers
of epileptogenic brain tissue. Utilizing HFOs for epilepsy surgery planning offers the promise …

Motivation: There is an ongoing search for definitive and reliable biomarkers to forecast or
predict imminent seizure onset, but to date most research has been limited to EEG with …

Recent studies show that the rate of cortical high frequency oscillations (HFOs) differentiates
epileptogenic tissue in individuals with epilepsy. However, HFO occurrence can vary widely …

For the past 2 decades, high-frequency oscillations (HFOs) have been enthusiastically
studied by the epilepsy community. Emerging evidence shows that HFOs harbor great …